About Refined Science

RefinedScience is building the biological foundation for better drug development. We integrate single-cell molecular data, longitudinal clinical data, and laboratory validation to generate insights that improve drug development decisions.

Mission

To enable better drug development decisions by connecting human biology, clinical data, and computational insight into a unified, decision-ready framework.

Vision

A future where every drug development decision is informed by real human biology, reducing failure, accelerating timelines, and bringing more effective therapies to patients.

Our Team

Meet the team turning complex biology into actionable insight

Brett Atwood, JD

President

Grant Weller, PhD

Chief Technology Officer

Dan Pollyea, MD, MS

Chief Medical Officer

Chris Rusconi, PhD

Chief Scientific Officer

Clay Smith, MD

Chief Innovation Officer

Jeff Weness, MBA

VP, Growth & Strategy

Mike McGarry, MBA

VP, Corporate Development & Strategy

Sarah Staggs, PhD

Director, Scientific Program Management

Kent Riemondy, PhD

Director of Bioinformatics

Nazmul Islam, PhD, MS, MBA

Director of Data Science

Brett Stevens, PhD

Director, Translational Laboratory Research

Kevin Wehber

Sr. Director of Strategic Operations

Justin Dale

Director of Data Management

Frank Markson

Director of Technical Infrastructure

Jim Coates

Director of Data Engineering

Ian Shelton

Director of Corporate Development and Strategy

Jamie Reuben

Director of Clinical Data Management

Jairav Desai

Associate Director, Bioinformatics

The essential data layer for AI-driven medicine

Let’s build the evidence that moves your program forward.